Your browser doesn't support javascript.
loading
Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T > C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing.
Aalders, Jeffrey; Léger, Laurens; Demolder, Anthony; Muiño Mosquera, Laura; Coucke, Paul; Menten, Björn; De Backer, Julie; van Hengel, Jolanda.
Afiliação
  • Aalders J; Medical Cell Biology Research Group, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Building B, Entrance 36, 9000 Ghent, Belgium.
  • Léger L; Medical Cell Biology Research Group, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Building B, Entrance 36, 9000 Ghent, Belgium.
  • Demolder A; Center for Medical Genetics, Ghent University Hospital, Belgium and Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
  • Muiño Mosquera L; Center for Medical Genetics, Ghent University Hospital, Belgium and Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium; Department of Paediatrics, Division of Paediatric Cardiology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Coucke P; Center for Medical Genetics, Ghent University Hospital, Belgium and Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
  • Menten B; Center for Medical Genetics, Ghent University Hospital, Belgium and Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
  • De Backer J; Center for Medical Genetics, Ghent University Hospital, Belgium and Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium; Department of Cardiology, Ghent University Hospital, 9000 Ghent, Belgium.
  • van Hengel J; Medical Cell Biology Research Group, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Building B, Entrance 36, 9000 Ghent, Belgium. Electronic address: Jolanda.vanhengel@ugent.be.
Stem Cell Res ; 67: 103036, 2023 03.
Article em En | MEDLINE | ID: mdl-36724552
Marfan syndrome is an autosomal dominant genetic disorder resulting from pathogenic variants in FBN1 gene. FBN1 encodes for fibrillin-1, an important extracellular matrix protein. Impaired fibrillin-1 affects multiple organ systems, including the cardiovascular system. We generated an iPSC line carrying a heterozygous variant c.7754 T > C (p.Ile2585Thr, missense) in FBN1 from a patient with Marfan syndrome. Also, an isogenic control is generated, where the pathogenic variant is repaired using CRISPR-Cas9. This isogenic pair provides a valuable resource for in vitro disease modelling.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas / Síndrome de Marfan Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Stem Cell Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas / Síndrome de Marfan Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Stem Cell Res Ano de publicação: 2023 Tipo de documento: Article